Regulators approved controversial therapies amid excess deaths, questionable efficacy, and conflicts of interest.
https://www.levernews.com/the-deadly-secrets-behind-breakthrough-alzheimers-drugs/?utm_source=bsky&utm_medium=link&utm_campaign=bsky-prefill
https://www.levernews.com/the-deadly-secrets-behind-breakthrough-alzheimers-drugs/?utm_source=bsky&utm_medium=link&utm_campaign=bsky-prefill
Comments